J. Virol., 12 1996, 8318-8331, Vol 70, No. 12
Copyright © 1996, American Society for Microbiology

Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease

S Gunther, N Piwon, A Iwanska, R Schilling, H Meisel and H Will
Heinrich-Pette-Institut fur Experimentelle Virologie und Immunologie an der Universitat Hamburg, Federal Republic of Germany.

Little is known about the functional significance of hepatitis B virus (HBV) sequence heterogeneity. Here we analyzed the type, frequency, and function of mutations in the core promoter/enhancer II region of HBV in immunosuppressed patients. The major HBV population in immunosuppressed patients with severe liver disease had deletions, insertions, and/or base changes in this region. Such mutations were not found in immunosuppressed patients with mild disease. Except for two mutations, all created a hepatocyte nuclear factor 1 (HNF1) binding site or a potential HNF3 binding site. Occasionally, known binding sites for C/EBP and HNF4 were additionally duplicated. Eleven mutated core promoter prototype sequences were functionally tested in the context of a wild-type genome by transfection in Huh7 cells. Despite the diversity of mutations tested, all decreased steady-state levels of pre-C mRNA drastically and increased those of the C mRNA/ pregenomic RNA. This correlated with reduced levels of secreted hepatitis B e antigen and increased intracellular levels of core and Pol proteins and replicative HBV DNA intermediates. The levels of secreted HBV DNA-containing particles were also increased although most of the mutations reduced the levels of pre-S/S mRNA and pre-S1, and pre-S2 proteins as well as secretion of hepatitis B surface antigen. These data reveal a novel class of HBV variants with HNF1 binding sites in the core promoter which are characterized by a defect in hepatitis B e antigen expression, enhanced replication, and altered protein levels, all probably mediated by altered transcription factor binding. The phenotype of these variants and their prevalence only in immunosuppressed patients with severe liver disease may indicate that they play a role in pathogenesis.

This article has been cited by other articles:

• Chou, Y-C, Yu, M-W, Wu, C-F, Yang, S-Y, Lin, C-L, Liu, C-J, Shih, W-L, Chen, P-J, Liaw, Y-F, Chen, C-J (2008). Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma. Gut 57: 91-97 [Abstract] [Full Text]  
• Meuleman, P., Libbrecht, L., Wieland, S., De Vos, R., Habib, N., Kramvis, A., Roskams, T., Leroux-Roels, G. (2006). Immune Suppression Uncovers Endogenous Cytopathic Effects of the Hepatitis B Virus. J. Virol. 80: 2797-2807 [Abstract] [Full Text]  
• Fujiwara, K., Tanaka, Y., Paulon, E., Orito, E., Sugiyama, M., Ito, K., Ueda, R., Mizokami, M., Naoumov, N. V. (2005). Novel Type of Hepatitis B Virus Mutation: Replacement Mutation Involving a Hepatocyte Nuclear Factor 1 Binding Site Tandem Repeat in Chronic Hepatitis B Virus Genotype E. J. Virol. 79: 14404-14410 [Abstract] [Full Text]  
• Franca, P. H. C., Gonzalez, J. E., Munne, M. S., Brandao, L. H., Gouvea, V. S., Sablon, E., Vanderborght, B. O. M. (2004). Strong Association between Genotype F and Hepatitis B Virus (HBV) e Antigen-Negative Variants among HBV-Infected Argentinean Blood Donors. J. Clin. Microbiol. 42: 5015-5021 [Abstract] [Full Text]  
• Parekh, S., Zoulim, F., Ahn, S. H., Tsai, A., Li, J., Kawai, S., Khan, N., Trepo, C., Wands, J., Tong, S. (2003). Genome Replication, Virion Secretion, and e Antigen Expression of Naturally Occurring Hepatitis B Virus Core Promoter Mutants. J. Virol. 77: 6601-6612 [Abstract] [Full Text]  
• Xu, Z., Yen, T. S. B., Wu, L., Madden, C. R., Tan, W., Slagle, B. L., Ou, J.-h. (2002). Enhancement of Hepatitis B Virus Replication by Its X Protein in Transgenic Mice. J. Virol. 76: 2579-2584 [Abstract] [Full Text]  
• Petrosillo, N., Ippolito, G., Solforosi, L., Varaldo, P. E., Clementi, M., Manzin, A. (2000). Molecular Epidemiology of an Outbreak of Fulminant Hepatitis B. J. Clin. Microbiol. 38: 2975-2981 [Abstract] [Full Text]  
• Gilbert, S., Galarneau, L., Lamontagne, A., Roy, S., Bélanger, L. (2000). The Hepatitis B Virus Core Promoter Is Strongly Activated by the Liver Nuclear Receptor Fetoprotein Transcription Factor or by Ectopically Expressed Steroidogenic Factor 1. J. Virol. 74: 5032-5039 [Abstract] [Full Text]  
• Preikschat, P., Meisel, H., Will, H., Günther, S. (1999). Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. J. Gen. Virol. 80: 2685-2691 [Abstract] [Full Text]  
• zu Putlitz, J., Lanford, R. E., Carlson, R. I., Notvall, L., de la Monte, S. M., Wands, J. R. (1999). Properties of Monoclonal Antibodies Directed against Hepatitis B Virus Polymerase Protein. J. Virol. 73: 4188-4196 [Abstract] [Full Text]  
• Li, J., Buckwold, V. E., Hon, M.-w., Ou, J.-h. (1999). Mechanism of Suppression of Hepatitis B Virus Precore RNA Transcription by a Frequent Double Mutation. J. Virol. 73: 1239-1244 [Abstract] [Full Text]  
• Baumert, T. F., Marrone, A., Vergalla, J., Liang, T. J. (1998). Naturally Occurring Mutations Define a Novel Function of the Hepatitis B Virus Core Promoter in Core Protein Expression. J. Virol. 72: 6785-6795 [Abstract] [Full Text]  
• Günther, S., Sommer, G., Von Breunig, F., Iwanska, A., Kalinina, T., Sterneck, M., Will, H. (1998). Amplification of Full-Length Hepatitis B Virus Genomes from Samples from Patients with Low Levels of Viremia: Frequency and Functional Consequences of PCR-Introduced Mutations. J. Clin. Microbiol. 36: 531-538 [Abstract] [Full Text]  
• Gunther, S, Piwon, N, Will, H (1998). Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter. J. Gen. Virol. 79: 375-380 [Abstract]  
• Fourel, G., Ringeisen, F., Flajolet, M., Tiollais, P., Buendia, M. A. (1998). Functional Analysis of Ground Squirrel Hepatitis Virus Enhancer II. J. Virol. 72: 1616-1622 [Abstract] [Full Text]